Assessment of fatigue in adult patients with sickle cell disease: Use of the functional assessment of chronic illness therapy—Fatigue (FACIT‐fatigue) questionnaire

Geoffrey Cheminet,Anne Corbasson,Marie Charmettan,Walid Namaoui,Djamal Khimoud,Edouard Flamarion,Adrien Michon,Emmanuel Lafont,Jacques Pouchot,Brigitte Ranque,Jean‐Benoît Arlet
DOI: https://doi.org/10.1111/bjh.19568
2024-05-29
British Journal of Haematology
Abstract:Fatigue is a major symptom of adult patients with sickle cell disease (SCD). To assess the burden of fatigue in our cohort, 102 adult patients with SCD at steady‐state filled the FACIT‐Fatigue questionnaire (ranging from 0 (worst imaginable fatigue) to 52 (no fatigue)). Median [IQR] FACIT‐Fatigue score was 29 [22–37], indicating moderate‐to‐severe fatigue. In a multivariate analysis, the FACIT‐Fatigue score was significantly associated with female sex, high body mass index, high level of stress, poor sleep quality, and number of previous episodes of acute chest syndrome, but not with the genotype or the haemoglobin level. Summary Few studies have used validated scales to assess the intensity and determinants of fatigue, a major symptom of sickle cell disease (SCD). We aimed to assess the level of basal fatigue in adult patients with SCD, using the Functional Assessment of Chronic Illness Therapy—Fatigue (FACIT‐Fatigue) questionnaire. We prospectively included 102 stable adult outpatients with SCD over 2 months, who answered the FACIT‐Fatigue (ranging from 0 (worst imaginable fatigue) to 52 (no fatigue)) and reported on the intensity of fatigue and its impact on quality of life. The cut‐off for significant fatigue was <34. The median [IQR] FACIT‐Fatigue score was 29 [22–37], indicating moderate‐to‐severe fatigue. In a multivariate analysis, the FACIT‐Fatigue score was significantly associated with female sex, high body mass index, high level of stress, poor sleep quality, and number of previous episodes of acute chest syndrome, but not with the genotype or the haemoglobin level. Most adult patients with SCD experience significant and sometimes intense fatigue; this is probably due to several factors, including disease activity. Fatigue should be evaluated systematically during consultations and in patient education programmes and as an end‐point in therapeutic trials.
hematology
What problem does this paper attempt to address?